Anthranilic acid amides and the use thereof as medicaments

US7122547B1 · kind B1 · utility

Assignees

• SCHERING CORPORATION · US
• Novartis AG · CH

Inventors

• Andreas Huth · Berlin, DE
• Dieter Seidelmann · Berlin, DE
• Karl-Heinz Thierauch · Berlin, DE
• Guido Bold · Gipf-Oberfrick, CH
• Paul W. Manley · Arlesheim, CH
• Pascal Furet · Basel, CH
• Jeanette Marjorie Wood · Biel-Benken, CH
• Jurgen Mestan · Denzlingen, DE
• Jose Brüggen · Riehen, CH
• Stefano Ferrari · Muttenz, CH
• Martin Kruger · Berlin, DE
• Eckhard Ottow · Berlin, DE
• Andreas Menrad · Berlin, DE
• Michael Schirner · Berlin, DE

Key dates

• Filing date: Nov 9, 1999
• Grant date: Oct 17, 2006
• Expiry date: Nov 9, 2019

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to anthranilic acid amides and the use thereof as medicaments for the treatment of diseases that are triggered by persistent angiogenesis, in addition to intermediate products in the production of anthranilic acid amides.